A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

Clinical trial NCT01203930 · TERMINATED

Trial details

NCT number: NCT01203930
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)

Start date: 2010-10-01
Primary completion: 2015-08-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.